Management of vyanga with the medicine vatankuradi lepa,chandanadi ghan vati,and procedure mechanical exfoliation

A clinical study of vatankuradi lepa and microderma abrasion alongwith chandnadi ghan vati in the management of vyanga w.s.r. melasma - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109198

Enrollment

Registered

2026-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical sign & symptoms of Vyanga such as niruj,tanu,shyav,mandal, willing to sign the consent form.Patients of either sex. Patient fit for taking this medicine.

Exclusion criteria

Exclusion criteria: Patient below 18 yrs and above 60 yrs. Female patients having pregnancy, taking OCP and lactating mothers. Melasma due to tubercular therapy or malignant cases. Diagnosed patients of Hyperglycemia (Diabetes), Hypertension, Thyroid disorder,Carcinoma, Burns, Herpes, Eczema, Psoriasis, Measles, Chickenpox, Leucoderma and Leprosy. Person suffering from any infective or contagious skin disease or under medication with antibiotics, antifungal and steroid. Patients of uncontrolled hormonal disease. Patients who are reporting allergic history of trial drugs.

Design outcomes

Primary

Measure	Time frame
To reduce classical sign and symptoms vyanga such as tanu,shyav mandalTimepoint: The outcome will be assessed after 2 month	—

Secondary

Measure	Time frame
Effective management of vyanga by relieving the symptomssuch as tanu,shyav mandalTimepoint: After 2 months of study	—

Countries

India

Contacts

Public ContactDr vandana saraf

Govt dhanwantari ayurvedic medical college and hospital ujjain M.P.

vandana13ishnavi@gmail.com8085740020

Outcome results